Brief: Trevi Therapeutics Announces Pricing Of $150 Million Underwritten Offering Of Common Stock
17/04/2026 03:42
April 16 (Reuters) - Trevi Therapeutics Inc TRVI.O: TREVI THERAPEUTICS ANNOUNCES PRICING OF $150 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK TREVI THERAPEUTICS INC - PRICES 11.6 MILLION SHARE OFFERING AT $13.00/SHARE FOR $150 MILLION GROSS PROCEEDS Source text: ID:nGNX6KMJ5 Further company coverage: TRVI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million